Healthcare FDA’s accelerated approval process is good enough for cancer and AIDS. Why not Alzheimer’s? Healthcare / 3 years ago by George Vradenburg, opinion contributor 09/22/21 2:30 PM ET
Health Care House Democrats ramp up probe of FDA approval of Alzheimer’s drug Health Care / 3 years ago by Nathaniel Weixel 09/02/21 1:33 PM ET
Healthcare An Alzheimer’s drug appears promising, but Medicare should wait to cover it Healthcare / 3 years ago by Drs. Christine Ritchie and Adith Sekaran, opinion contributors 08/12/21 4:00 PM ET
Healthcare Medicare must clear patient access to Alzheimer’s treatments Healthcare / 3 years ago by George Vradenburg, opinion contributor 06/29/21 3:45 PM ET
Health Care Biogen CEO says $56K a year for new Alzheimer’s drug is a ‘fair’ price Health Care / 4 years ago by Joseph Choi 06/07/21 4:35 PM ET
